Drug Development

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

At DCAT's annual meeting, Bill Downey, president of the market research firm High Tech Business Decisions, summarized results from its latest survey on biopharmaceutical outsourcing.

Biopharmaceutical Outsourcing Continues to Grow

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Industry is joining with academia and global health leaders to examine new approaches to biotech manufacturing.

Biotech Manufacturers Explore Global Access and Supply Chain Hurdles

Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.

Novo Nordisk Builds Manufacturing Facility in North Carolina

A team of Bristol-Myers Squibb scientists will work in a new laboratory at the National Institute of Bioprocessing Research and Training facility in Dublin, Ireland.

Bristol-Myers Squibb Collaborates with Bioprocessing Institute in Ireland

Collaboration will provide for unified development and manufacture of antibody drug conjugates.

CMC Biologics and IDT Biologika Collaborate on ADC Manufacturing

The Human Vaccines Project brings together academic research centers, industrial partners, nonprofit organizations, and governments to address the primary scientific barriers to developing new vaccines and immunotherapies.

Pfizer Joins the Human Vaccines Project

During a clinical trial of 48 participants, 100% of those that received the TV003 vaccine were protected from infection.

NIH Investigational Dengue Vaccine Proves 100% Effective

The author discusses how x-ray spectrometry can be an effective way to measure these impurities and meet regulatory guidelines.

Meeting USP Guidelines for Elemental Impurity Analysis with X-ray Fluorescence Spectrometry

The author discusses key process parameters and shows how a process optimization template can be used to improve this key operation.

Optimizing Tablet Compression

Irwin Silverstein, PhD, is vice-president and chief operating officer at International Pharmaceutical Excipients Auditing, 1655 N. Fort Myer Drive, Suite 700, Arlington, VA 22209, tel. 703.351.5266.

The author discusses key areas of focus and presents best practices from the International Pharmaceutical Excipients Council (IPEC).

Formulation and Drug Delivery